Cara Therapeutics reported $-28922000 in Net Income for its second fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Acadia Pharmaceuticals ACAD:US $ -43M 46M
Aerie Pharmaceuticals AERI:US $ -49M 1M
Antares Pharma ATRS:US $ 2M 5M
Biodelivery Sciences International BDSI:US $ 1M 3M
Chugai Pharma 4519:JP Y 60133M 9374M
Depomed DEPO:US $ -10.52M 23.98M
Endo International Ordinary Shares ENDP:US $ -75.89M 86.44M
Halozyme Therapeutics HALO:US $ 25.82M 31.92M
Horizon Pharma HZNP:US $ 292.84M 372.85M
JAZZ PHA JAZZ:US $ 148.23M 33.43M
Johnson & Johnson JNJ:US $ 3554M 72M
Neurocrine Biosciences NBIX:US $ 79M 42M
Pacira Pharmaceuticals PCRX:US $ -7.27M 15.43M
Pfizer PFE:US $ 3426M 25M
Redhill Biopharma RDHL:US $ -18.64M 2.59M
Revance Therapeutics RVNC:US $ -61M 1M
Teva Pharmaceutical Industries TEVA:US $ -4349M 4489M
Vanda Pharmaceuticals VNDA:US $ 8.71M 8.23M